PHIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Phio Pharmaceuticals Corp.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$0.87−0.00 (-0.25%)
Close on Oct 19, 2026
- Market cap
- $10.09M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$1.2411 (−58.82%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $10.09M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 0.80
- Dividend yield
- –
- Free cash flow yield
- -120.95%
Fundamentals
- Net income
- -$12.90M
- EPS, diluted
- -$1.39
- Free cash flow
- -$12.21M
- Book value per share
- $1.08
- Diluted shares
- 12M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
–
Operating income
-$13.47M
Net income
-$12.90M
EPS, diluted
-$1.39
Free cash flow
-$12.21M
Reported periodTrailing twelve months